Ajax Health LLC
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Ajax Health LLC - overview
Established
2017
Location
Menlo Park, CA, US
Primary Industry
Biotechnology
About
Ajax Health LLC is a medical technology company dedicated to developing innovative solutions that enhance patient outcomes and streamline healthcare delivery. Their focus on advanced medical devices supports diverse clinical needs in healthcare. Founded in 2017 in Menlo Park, US, Ajax Health LLC develops medical technology solutions to improve healthcare delivery. The company has undergone strategic pivots, focusing on innovative product development.
Duke Rohlen, the founder and CEO, leads the company, which has successfully raised USD 100. 00 mn in total funding across 4 deals, with the latest funding from HealthQuest Capital and Polaris Partners on September 30, 2019. Ajax Health specializes in creating advanced medical devices and systems aimed at enhancing patient care and operational efficiency. Their product portfolio predominantly serves the cardiovascular and surgical applications sectors, targeting healthcare providers, hospitals, and specialty clinics in North America and Europe.
The solutions are designed to improve access to care and address critical challenges in the medtech industry. Ajax Health generates revenue through direct sales and B2B partnerships with healthcare providers and distributors. The company focuses on supplying innovative medical devices to hospitals and specialty clinics, utilizing established contracts that may include bulk purchasing agreements or subscription services for ongoing support. Their flagship products, integral to their revenue generation, are positioned competitively to reflect the value delivered to healthcare institutions.
Ajax Health plans to utilize the recent funding of USD 100. 00 mn raised on September 30, 2019, to support the design and launch of new products aimed at enhancing healthcare outcomes. The company is strategically targeting expansion into new geographic regions, particularly in Europe, by 2023. This growth initiative will bolster their market presence and address the critical needs in medical technology.
Current Investors
KKR, Polaris Partners, Aisling Capital
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals
Website
www.ajaxhealth.com
Verticals
Manufacturing
Company Stage
Series C
Total Amount Raised
Subscriber access only
Ajax Health LLC - key contacts
| Name | Position | Start Date | End Date | Vcard | Bio | ||
|---|---|---|---|---|---|---|---|
| Chairman of the Board | BM | ||||||
| Director Board Of Directors | BM |
BM Board Member
Want to see more?
Request a demo for full access to this profile

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.